Back to Search Start Over

Pharmacology of N-desmethylclozapine.

Authors :
Lameh J
Burstein ES
Taylor E
Weiner DM
Vanover KE
Bonhaus DW
Source :
Pharmacology & therapeutics [Pharmacol Ther] 2007 Aug; Vol. 115 (2), pp. 223-31. Date of Electronic Publication: 2007 May 21.
Publication Year :
2007

Abstract

Currently available treatments for schizophrenia have limited efficacy and are generally poorly tolerated. However, among these antipsychotic agents, clozapine stands apart in having generally superior motoric tolerability and efficacy. One intriguing possibility, based on clinical correlations, receptor activity profiles and studies with animal models predictive of antipsychotic or cognitive action is that the activity of N-desmethylclozapine (NDMC), a major metabolite of clozapine, may, at least in part, underlie the unique efficacy of clozapine. In this review we compare the pharmacological properties of NDMC to those of clozapine and consider how they may contribute to the overall clinical properties of clozapine. We also consider whether NDMC, in its own right, might be a superior antipsychotic drug.

Details

Language :
English
ISSN :
0163-7258
Volume :
115
Issue :
2
Database :
MEDLINE
Journal :
Pharmacology & therapeutics
Publication Type :
Academic Journal
Accession number :
17583355
Full Text :
https://doi.org/10.1016/j.pharmthera.2007.05.004